Bio Career Breakfast at Lek's Biopharmaceuticals Mengeš creates opportunities for Slovenian experts at home
- For the second time in a row, Lek's business unit Biopharmaceuticals Mengeš has invited Slovenian natural science experts working or studying abroad, to an event presenting excellent career opportunities in the home environment.
- Bio Career Breakfast is Lek's response to the modern migration trend among the highly educated workforce and an example of Lek's initiative to create a stimulating work environment for the top Slovenian experts.
- In 2016, Lek employed 10 Slovenian experts who participated in the first Bio Career Breakfast last January, thus retaining domestic knowledge and talents in Slovenia.
For the second year in a row, Lek's business unit Biopharmaceuticals Mengeš has organised Bio Career Breakfast, an event, to which highly educated Slovenian natural science experts working or studying abroad, were invited. More than 70 Slovenian experts attended the event, organised by Lek's Biopharmaceuticals Mengeš in collaboration with the Slovene Human Resources and Scholarship Fund and the Association of Slovenes Educated Abroad (VTIS).
Lek has made the creation of a stimulating work environment an important part of their operation and despite the harsh conditions on the market, they have been continuously recruiting new associates in recent years; last year they launched an innovative initiative, aimed at Slovenian natural science experts working abroad, to return to their home environment.
»As a leading part of the global pharmaceutical company Novartis, Lek strives to offer to Slovenian experts an opportunity to work in the Slovenian, domestic environment, while at the same time, being part of an international company, providing contact with the best expertise worldwide. For this purpose, we are today organising at Biopharmaceuticals Mengeš the second consecutive Bio Career Breakfast, dedicated to the presentation of development and production of biosimilars, our vision in this field and employment opportunities for Slovenian experts who work or study abroad and are considering returning to Slovenia,» said Matjaž Oven, PhD, Site Head Biopharmaceuticals Mengeš.
Biopharmaceuticals is namely the fastest growing branch of the pharmaceutical industry and offers many career opportunities for professionals, especially pharmacists, chemists, biotechnologists, microbiologists and biochemists.
The response to the event was excellent, with more than 70 people attending. In 2016, Lek employed 10 Slovenian experts who participated in the first Bio Career Breakfast in January last year, thus retaining domestic knowledge and talents in Slovenia.
Lek, a Sandoz company, is one of the key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for technologically demanding products and technologies; a key global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar active ingredients and products; a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and the Commonwealth of Independent States (CIS), and is responsible for marketing and sales of Sandoz products on the Slovenian market. For further information, please visit www.lek.si.
Sandoz is a global leader in generic and biosimilar pharmaceuticals. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10.1 billion. In 2015, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.
Sandoz is on Twitter. Sign up to follow @Sandoz_global at http://twitter.com/Sandoz_Global (link is external).
For further details visit www.sandoz.com/makingaccesshappen
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. For more information, please visit www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32